MIM
MetLife Investment Management’s Foghorn Therapeutics FHTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
+21,603
| New | +$102K | ﹤0.01% | 2532 |
|
|
2024
Q4 | – | Sell |
-15,898
| Closed | -$148K | – | 2827 |
|
|
2024
Q3 | $148K | Buy |
15,898
+8,958
| +129% | +$83.4K | ﹤0.01% | 2441 |
|
|
2024
Q2 | $39.9K | Buy |
+6,940
| New | +$39.9K | ﹤0.01% | 2790 |
|
|
2023
Q4 | – | Sell |
-11,445
| Closed | -$57.2K | – | 2841 |
|
|
2023
Q3 | $57.2K | Hold |
11,445
| – | – | ﹤0.01% | 2810 |
|
|
2023
Q2 | $80.6K | Buy |
+11,445
| New | +$80.6K | ﹤0.01% | 2802 |
|
|
2023
Q1 | – | Sell |
-13,632
| Closed | -$87K | – | 2801 |
|
|
2022
Q4 | $87K | Hold |
13,632
| – | – | ﹤0.01% | 2646 |
|
|
2022
Q3 | $117K | Hold |
13,632
| – | – | ﹤0.01% | 2596 |
|
|
2022
Q2 | $185K | Hold |
13,632
| – | – | ﹤0.01% | 2379 |
|
|
2022
Q1 | $208K | Buy |
13,632
+4,949
| +57% | +$75.4K | ﹤0.01% | 2333 |
|
|
2021
Q4 | $199K | Hold |
8,683
| – | – | ﹤0.01% | 2056 |
|
|
2021
Q3 | $121K | Buy |
+8,683
| New | +$121K | ﹤0.01% | 2353 |
|